Status:
COMPLETED
Towards Reducing Resistance and Hematological Toxicity of Linezolid
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
Monash University
Conditions:
Infection
Adverse Effects
Eligibility:
All Genders
18+ years
Brief Summary
The study will evaluate and improve the performance of pharmaco-statistical models previously developed in the compassionate use program in patients being treated with linezolid under clinical usage c...
Detailed Description
Epidemiologic information to be collected At baseline (upon signing informed consent), the following information will be collected: Demographic data - age, sex, height, weight, state of birth, previo...
Eligibility Criteria
Inclusion
- Males or females greater than 18 years of age.
- All patients will remain in the hospital for pharmacokinetic sampling.
- All subjects must be on the medication linezolid as part of their standard of care.
Exclusion
- Patients with renal failure who receive peritoneal dialysis, hemodialysis or hemofiltration.
- Any contraindication to blood sampling
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
End Date :
February 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00177723
Start Date
August 1 2005
End Date
February 1 2007
Last Update
December 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213